Top

Osteoporosis International

Published in:

01-03-2019 | Original Article

Disrupted radial and tibial microarchitecture in patients with monoclonal gammopathy of undetermined significance

Authors: E.M. Stein, A. Dash, M. Bucovsky, S. Agarwal, J. Fu, S. Lentzsch, E. Shane

Published in: Osteoporosis International | Issue 3/2019

Abstract

Summary

Patients with monoclonal gammopathy of undetermined significance (MGUS) had abnormalities in volumetric BMD (vBMD), microarchitecture, and stiffness at both the radius and tibia by high-resolution peripheral quantitative CT compared to matched controls. This is the first report demonstrating that patients with MGUS have microarchitectural deficits at multiple skeletal sites.

Introduction

Fracture risk is elevated in patients with monoclonal gammopathy of undetermined significance (MGUS). However, the pathogenesis of bone disease in these patients is poorly understood. Prior work using high-resolution peripheral CT (HRpQCT) demonstrated abnormal microarchitecture at the radius, with predominantly cortical abnormalities. We hypothesized that patients with MGUS have abnormal microarchitecture at both radius and tibia compared to controls, reflecting global skeletal effects of the disease.

Methods

This case-control study enrolled 36 subjects; patients with MGUS (n = 12) were matched 1:2 by age, sex, and race to controls (n = 24). Areal BMD (aBMD) was measured by DXA, vBMD, and microarchitecture by HRpQCT, and whole bone stiffness by finite element analysis. Serum was drawn for markers of bone metabolism and inflammation.

Results

By DXA, MGUS patients had lower aBMD at the lumbar spine, femoral neck, and 1/3 radius. Markers of bone metabolism and inflammation did not differ. By HRpQCT at the radius, MGUS patients had lower total, trabecular and cortical density, lower trabecular number, and greater trabecular separation and heterogeneity. At the tibia, MGUS patients had lower total and trabecular density, lower trabecular number, greater separation and heterogeneity, and lower whole bone stiffness.

Conclusions

Patients with MGUS had lower vBMD, cortical, and trabecular abnormalities at the radius compared to matched controls. At the tibia, trabecular abnormalities predominated. These results suggest that in addition to previously described cortical deficits, deterioration of trabecular bone may contribute to a generalized skeletal fragility in patients with MGUS.

Melton LJ 3rd, Rajkumar SV, Khosla S, Achenbach SJ, Oberg AL, Kyle RA (2004) Fracture risk in monoclonal gammopathy of undetermined significance. J Bone Miner Res 19(1):25–30. https://doi.org/10.1359/JBMR.0301212 CrossRefPubMed

Gregersen H, Jensen P, Gislum M, Jorgensen B, Sorensen HT, Norgaard M (2006) Fracture risk in patients with monoclonal gammopathy of undetermined significance. Br J Haematol 135(1):62–67. https://doi.org/10.1111/j.1365-2141.2006.06269.x CrossRefPubMed

Veronese N, Luchini C, Solmi M, Sergi G, Manzato E, Stubbs B (2018) Monoclonal gammopathy of undetermined significance and bone health outcomes: a systematic review and exploratory meta-analysis. J Bone Miner Metab 36(1):128–132. https://doi.org/10.1007/s00774-017-0817-8 CrossRefPubMed

Berenson JR, Anderson KC, Audell RA, Boccia RV, Coleman M, Dimopoulos MA, Drake MT, Fonseca R, Harousseau JL, Joshua D, Lonial S, Niesvizky R, Palumbo A, Roodman GD, San-Miguel JF, Singhal S, Weber DM, Zangari M, Wirtschafter E, Yellin O, Kyle RA (2010) Monoclonal gammopathy of undetermined significance: a consensus statement. Br J Haematol 150(1):28–38. https://doi.org/10.1111/j.1365-2141.2010.08207.x CrossRefPubMed

Therneau TM, Kyle RA, Melton LJ 3rd, Larson DR, Benson JT, Colby CL, Dispenzieri A, Kumar S, Katzmann JA, Cerhan JR, Rajkumar SV (2012) Incidence of monoclonal gammopathy of undetermined significance and estimation of duration before first clinical recognition. Mayo Clin Proc 87(11):1071–1079. https://doi.org/10.1016/j.mayocp.2012.06.014 CrossRefPubMedPubMedCentral

Kyle RA, Therneau TM, Rajkumar SV, Larson DR, Plevak MF, Offord JR, Dispenzieri A, Katzmann JA, Melton LJ 3rd (2006) Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med 354(13):1362–1369. https://doi.org/10.1056/NEJMoa054494 CrossRefPubMed

Golombick T, Diamond T (2008) Prevalence of monoclonal gammopathy of undetermined significance/myeloma in patients with acute osteoporotic vertebral fractures. Acta Haematol 120(2):87–90. https://doi.org/10.1159/000162282 CrossRefPubMed

Bouvard B, Royer M, Chappard D, Audran M, Hoppe E, Legrand E (2010) Monoclonal gammopathy of undetermined significance, multiple myeloma, and osteoporosis. Joint Bone Spine 77(2):120–124. https://doi.org/10.1016/j.jbspin.2009.12.002 CrossRefPubMed

Farr JN, Zhang W, Kumar SK, Jacques RM, Ng AC, McCready LK, Rajkumar SV, Drake MT (2014) Altered cortical microarchitecture in patients with monoclonal gammopathy of undetermined significance. Blood 123(5):647–649. https://doi.org/10.1182/blood-2013-05-505776 CrossRefPubMedPubMedCentral

10.

Ng AC, Khosla S, Charatcharoenwitthaya N, Kumar SK, Achenbach SJ, Holets MF, McCready LK, Melton LJ 3rd, Kyle RA, Rajkumar SV, Drake MT (2011) Bone microstructural changes revealed by high-resolution peripheral quantitative computed tomography imaging and elevated DKK1 and MIP-1alpha levels in patients with MGUS. Blood 118(25):6529–6534. https://doi.org/10.1182/blood-2011-04-351437 CrossRefPubMedPubMedCentral

11.

Stein EM, Liu XS, Nickolas TL, Cohen A, Thomas V, McMahon DJ, Zhang C, Yin PT, Cosman F, Nieves J, Guo XE, Shane E (2010) Abnormal microarchitecture and reduced stiffness at the radius and tibia in postmenopausal women with fractures. J Bone Miner Res 25(12):2572–2581. https://doi.org/10.1002/jbmr.152 CrossRefPubMedPubMedCentral

12.

Stein EM, Liu XS, Nickolas TL, Cohen A, Thomas V, McMahon DJ, Zhang C, Cosman F, Nieves J, Greisberg J, Guo XE, Shane E (2011) Abnormal microarchitecture and stiffness in postmenopausal women with ankle fractures. J Clin Endocrinol Metab 96(7):2041–2048. https://doi.org/10.1210/jc.2011-0309 CrossRefPubMedPubMedCentral

13.

Stein EM, Liu XS, Nickolas TL, Cohen A, McMahon DJ, Zhou B, Zhang C, Kamanda-Kosseh M, Cosman F, Nieves J, Guo XE, Shane E (2012) Microarchitectural abnormalities are more severe in postmenopausal women with vertebral compared to nonvertebral fractures. J Clin Endocrinol Metab 97(10):E1918–E1926. https://doi.org/10.1210/jc.2012-1968 CrossRefPubMedPubMedCentral

14.

Stein EM, Silva BC, Boutroy S, Zhou B, Wang J, Udesky J, Zhang C, McMahon DJ, Romano M, Dworakowski E, Costa AG, Cusano N, Irani D, Cremers S, Shane E, Guo XE, Bilezikian JP (2013) Primary hyperparathyroidism is associated with abnormal cortical and trabecular microstructure and reduced bone stiffness in postmenopausal women. J Bone Miner Res 28(5):1029–1040. https://doi.org/10.1002/jbmr.1841 CrossRefPubMed

15.

Stein EM, Kepley A, Walker M, Nickolas TL, Nishiyama K, Zhou B, Liu XS, McMahon DJ, Zhang C, Boutroy S, Cosman F, Nieves J, Guo XE, Shane E (2014) Skeletal structure in postmenopausal women with osteopenia and fractures is characterized by abnormal trabecular plates and cortical thinning. J Bone Miner Res 29(5):1101–1109CrossRefPubMed

16.

Agarwal S, Rosete F, Zhang C, McMahon DJ, Guo XE, Shane E, Nishiyama KK (2016) In vivo assessment of bone structure and estimated bone strength by first- and second-generation HR-pQCT. Osteoporos Int 27(10):2955–2966. https://doi.org/10.1007/s00198-016-3621-8 CrossRefPubMed

17.

Drake MT (2014) Unveiling skeletal fragility in patients diagnosed with MGUS: no longer a condition of undetermined significance? J Bone Miner Res 29(12):2529–2533. https://doi.org/10.1002/jbmr.2387 CrossRefPubMed

18.

Terpos E, Dimopoulos MA (2014) Less strength and more fractures for MGUS bones. Blood 123(5):603–604. https://doi.org/10.1182/blood-2013-11-539973 CrossRefPubMed

19.

Kristinsson SY, Tang M, Pfeiffer RM, Bjorkholm M, Blimark C, Mellqvist UH, Wahlin A, Turesson I, Landgren O (2010) Monoclonal gammopathy of undetermined significance and risk of skeletal fractures: a population-based study. Blood 116(15):2651–2655. https://doi.org/10.1182/blood-2010-04-282848 CrossRefPubMedPubMedCentral

20.

Pecherstorfer M, Seibel MJ, Woitge HW, Horn E, Schuster J, Neuda J, Sagaster P, Kohn H, Bayer P, Thiebaud D, Ludwig H (1997) Bone resorption in multiple myeloma and in monoclonal gammopathy of undetermined significance: quantification by urinary pyridinium cross-links of collagen. Blood 90(9):3743–3750PubMed

21.

Pepe J, Petrucci MT, Mascia ML, Piemonte S, Fassino V, Romagnoli E, Minisola S (2008) The effects of alendronate treatment in osteoporotic patients affected by monoclonal gammopathy of undetermined significance. Calcif Tissue Int 82(6):418–426. https://doi.org/10.1007/s00223-008-9145-2 CrossRefPubMed

22.

Diamond T, Levy S, Smith A, Day P, Manoharan A (2001) Non-invasive markers of bone turnover and plasma cytokines differ in osteoporotic patients with multiple myeloma and monoclonal gammopathies of undetermined significance. Intern Med J 31(5):272–278CrossRefPubMed

23.

Pepe J, Petrucci MT, Nofroni I, Fassino V, Diacinti D, Romagnoli E, Minisola S (2006) Lumbar bone mineral density as the major factor determining increased prevalence of vertebral fractures in monoclonal gammopathy of undetermined significance. Br J Haematol 134(5):485–490. https://doi.org/10.1111/j.1365-2141.2006.06217.x CrossRefPubMed

24.

Politou M, Terpos E, Anagnostopoulos A, Szydlo R, Laffan M, Layton M, Apperley JF, Dimopoulos MA, Rahemtulla A (2004) Role of receptor activator of nuclear factor-kappa B ligand (RANKL), osteoprotegerin and macrophage protein 1-alpha (MIP-1a) in monoclonal gammopathy of undetermined significance (MGUS). Br J Haematol 126(5):686–689. https://doi.org/10.1111/j.1365-2141.2004.05092.x CrossRefPubMed

25.

Lentzsch S, Gries M, Janz M, Bargou R, Dorken B, Mapara MY (2003) Macrophage inflammatory protein 1-alpha (MIP-1 alpha ) triggers migration and signaling cascades mediating survival and proliferation in multiple myeloma (MM) cells. Blood 101(9):3568–3573. https://doi.org/10.1182/blood-2002-08-2383 CrossRefPubMed

26.

Fu J, Li S, Feng R, Ma H, Sabeh F, Roodman GD, Wang J, Robinson S, Guo XE, Lund T, Normolle D, Mapara MY, Weiss SJ, Lentzsch S (2016) Multiple myeloma-derived MMP-13 mediates osteoclast fusogenesis and osteolytic disease. J Clin Invest 126(5):1759–1772. https://doi.org/10.1172/JCI80276 CrossRefPubMedPubMedCentral

27.

Jakob C, Zavrski I, Heider U, Brux B, Eucker J, Langelotz C, Sinha P, Possinger K, Sezer O (2002) Bone resorption parameters [carboxy-terminal telopeptide of type-I collagen (ICTP), amino-terminal collagen type-I telopeptide (NTx), and deoxypyridinoline (Dpd)] in MGUS and multiple myeloma. Eur J Haematol 69(1):37–42CrossRefPubMed

28.

Pecoraro V, Roli L, Germagnoli L, Banfi G (2015) The prognostic role of bone turnover markers in multiple myeloma patients: the impact of their assay. A systematic review and meta-analysis. Crit Rev Oncol Hematol 96(1):54–66. https://doi.org/10.1016/j.critrevonc.2015.05.001 CrossRefPubMed

29.

Fonseca R, Trendle MC, Leong T, Kyle RA, Oken MM, Kay NE, Van Ness B, Greipp PR (2000) Prognostic value of serum markers of bone metabolism in untreated multiple myeloma patients. Br J Haematol 109(1):24–29CrossRefPubMed

30.

Nishi Y, Atley L, Eyre DE, Edelson JG, Superti-Furga A, Yasuda T, Desnick RJ, Gelb BD (1999) Determination of bone markers in pycnodysostosis: effects of cathepsin K deficiency on bone matrix degradation. J Bone Miner Res 14(11):1902–1908. https://doi.org/10.1359/jbmr.1999.14.11.1902 CrossRefPubMed

31.

Delgado-Calle J, Sato AY, Bellido T (2017) Role and mechanism of action of sclerostin in bone. Bone 96:29–37. https://doi.org/10.1016/j.bone.2016.10.007 CrossRefPubMed

32.

Kristensen IB, Christensen JH, Lyng MB, Moller MB, Pedersen L, Rasmussen LM, Ditzel HJ, Abildgaard N (2014) Expression of osteoblast and osteoclast regulatory genes in the bone marrow microenvironment in multiple myeloma: only up-regulation of Wnt inhibitors SFRP3 and DKK1 is associated with lytic bone disease. Leuk Lymphoma 55(4):911–919. https://doi.org/10.3109/10428194.2013.820288 CrossRefPubMed

33.

Heider U, Kaiser M, Mieth M, Lamottke B, Rademacher J, Jakob C, Braendle E, Stover D, Sezer O (2009) Serum concentrations of DKK-1 decrease in patients with multiple myeloma responding to anti-myeloma treatment. Eur J Haematol 82(1):31–38. https://doi.org/10.1111/j.1600-0609.2008.01164.x CrossRefPubMed

34.

Kaiser M, Mieth M, Liebisch P, Oberlander R, Rademacher J, Jakob C, Kleeberg L, Fleissner C, Braendle E, Peters M, Stover D, Sezer O, Heider U (2008) Serum concentrations of DKK-1 correlate with the extent of bone disease in patients with multiple myeloma. Eur J Haematol 80(6):490–494. https://doi.org/10.1111/j.1600-0609.2008.01065.x CrossRefPubMed

Title: Disrupted radial and tibial microarchitecture in patients with monoclonal gammopathy of undetermined significance
Authors: E.M. Stein
A. Dash
M. Bucovsky
S. Agarwal
J. Fu
S. Lentzsch
E. Shane
Publication date: 01-03-2019
Publisher: Springer London
Published in: Osteoporosis International / Issue 3/2019
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-018-4787-z

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Disrupted radial and tibial microarchitecture in patients with monoclonal gammopathy of undetermined significance

Abstract

Summary

Introduction

Methods

Results

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Summary

Introduction

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 3/2019

Administrative healthcare data applied to fracture risk assessment

Multiple vitamin deficiencies additively increase the risk of incident fractures in Japanese postmenopausal women

Preoperative antithrombotic therapy and risk of blood transfusion and mortality following hip fracture surgery: a Danish nationwide cohort study

Correction to: Were VCF patients at higher risk of mortality following the 2009 publication of the vertebroplasty “sham” trials?

Long waiting time before tooth extraction may increase delayed wound healing in elderly Japanese

Cost-effectiveness of gastro-resistant risedronate tablets for the treatment of postmenopausal women with osteoporosis in France